litlas
ログインアカウント作成

Peter M. Ravdin

1976–2021 年に発表

57
論文数
26,762
被引用数
52
h 指数
57
i10 指数

被引用数

Peter M. Ravdin の年別被引用数1977 年: 被引用 3 件1978 年: 被引用 11 件1979 年: 被引用 15 件1980 年: 被引用 12 件1981 年: 被引用 22 件1982 年: 被引用 18 件1983 年: 被引用 11 件1984 年: 被引用 13 件1985 年: 被引用 16 件1986 年: 被引用 11 件1987 年: 被引用 15 件1988 年: 被引用 11 件1989 年: 被引用 13 件1990 年: 被引用 5 件1991 年: 被引用 2 件1992 年: 被引用 6 件1993 年: 被引用 7 件1994 年: 被引用 19 件1995 年: 被引用 20 件1996 年: 被引用 28 件1997 年: 被引用 29 件1998 年: 被引用 44 件1999 年: 被引用 54 件2000 年: 被引用 58 件2001 年: 被引用 99 件2002 年: 被引用 75 件2003 年: 被引用 81 件2004 年: 被引用 87 件2005 年: 被引用 144 件2006 年: 被引用 132 件2007 年: 被引用 138 件2008 年: 被引用 216 件2009 年: 被引用 220 件2010 年: 被引用 265 件2011 年: 被引用 274 件2012 年: 被引用 228 件2013 年: 被引用 239 件2014 年: 被引用 162 件2015 年: 被引用 176 件2016 年: 被引用 160 件2017 年: 被引用 179 件2018 年: 被引用 178 件2019 年: 被引用 718 件2020 年: 被引用 718 件2021 年: 被引用 602 件2022 年: 被引用 468 件2023 年: 被引用 304 件2024 年: 被引用 487 件2025 年: 被引用 208 件2026 年: 被引用 13 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,425 件、この内訳の 29.3%中国: 引用元論文 631 件、この内訳の 7.6%イギリス: 引用元論文 589 件、この内訳の 7.1%ドイツ: 引用元論文 402 件、この内訳の 4.9%イタリア: 引用元論文 382 件、この内訳の 4.6%カナダ: 引用元論文 359 件、この内訳の 4.3%オランダ: 引用元論文 302 件、この内訳の 3.7%フランス: 引用元論文 301 件、この内訳の 3.6%オーストラリア: 引用元論文 196 件、この内訳の 2.4%スペイン: 引用元論文 191 件、この内訳の 2.3%スイス: 引用元論文 188 件、この内訳の 2.3%ベルギー: 引用元論文 173 件、この内訳の 2.1%
0%29.3%その他 25.8%

機関

分野

  • Biochemistry, Genetics and Molecular Biology47.6%
  • Medicine39.9%
  • Computer Science4.2%
  • Health Professions1.4%
  • Neuroscience1.1%
  • Mathematics1%
  • その他4.8%

トピック

  • Breast Cancer Treatment Studies12.9%
  • HER2/EGFR in Cancer Research6%
  • Breast Lesions and Carcinomas4.1%
  • Cancer Genomics and Diagnostics3.2%
  • Estrogen and related hormone effects2.6%
  • Advanced Breast Cancer Therapies2.6%
  • その他68.6%

共著者

全論文

検索で開く
  1. Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

    著者: Joseph A. Sparano, Robert J. Gray, Della Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, John A. Olson, Tracy Lively, Sunil Badve, Thomas J. Saphner, Lynne I. Wagner, Timothy J. Whelan, Matthew J. Ellis, Soonmyung Paik, William C. Wood, Peter M. Ravdin, Maccon Keane, Henry Gómez, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Adam Brufsky, Deborah Toppmeyer, Virginia Kaklamani, Jeffrey L. Berenberg, Jeffrey S. Abrams, George W. Sledge - New England Journal of Medicine 2018 被引用: 2,369

  2. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

    著者: Fátima Cardoso, Laura J. van’t Veer, Jan Bogaerts, Leen Slaets, Giuseppe Viale, Suzette Delaloge, Jean‐Yves Pierga, Étienne Brain, Sylvain Causeret, Mauro Delorenzi, Annuska M. Glas, Vassilis Golfinopoulos, Theodora Goulioti, Susan Knox, Erika Matos, Bart Meulemans, Peter A. Neijenhuis, Ulrike Nitz, Rodolfo Passalacqua, Peter M. Ravdin, Isabel T. Rubio, Mahasti Saghatchian, Tineke J. Smilde, Christos Sotiriou, Lisette Stork, Carolyn Straehle, Geraldine Thomas, Alastair M. Thompson, Jacobus M. van der Hoeven, Peter Vuylsteke, René Bernards, Konstantinos Tryfonidis, Emiel J. Rutgers, Martine Piccart - New England Journal of Medicine 2016 被引用: 2,051

  3. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    著者: Bernard Asselain, William E. Barlow, John M.S. Bartlett, Jonas Bergh, Elizabeth Bergsten-Nordström, Judith M. Bliss, Francesco Boccardo, Clare Boddington, Jan Bogaerts, Gianni Bonadonna, Rosie Bradley, Étienne Brain, Jeremy Braybrooke, Philippe Broët, John Bryant, Julie Ann Burrett, David Cameron, Mike Clarke, Alan S. Coates, Robert L. Coleman, Raoul Charles Coombes, Candace R. Correa, Joe Costantino, Jack Cuzick, David N. Danforth, Nancy E. Davidson, Christina Davies, Lucy Davies, Angelo Di Leo, David Dodwell, Mitch Dowsett, Frances Duane, Vaughan Evans, Marianne Ewertz, Bernard Fisher, John Forbes, Leslie G. Ford, J.-C. Gazet, Richard D. Gelber, Lucy Gettins, Luca Gianni, Michael Gnant, Jon Godwin, Aron Goldhirsch, Pamela J. Goodwin, Richard Gray, Daniel F. Hayes, Catherine Hill, James N. Ingle, Reshma Jagsi, R. Jakesz, Sam James, Wolfgang Janni, Hui Liu, Zulian Liu, Caroline Lohrisch, Sibylle Loibl, Liz MacKinnon, Andreas Makris, Eleftherios P. Mamounas, Gurdeep Mannu, Miguel Martín, S. Mathoulin, L. Mauriac, Paul McGale, Theresa McHugh, Philip Morris, Hirofumi Mukai, Larry Norton, Yasuo Ohashi, Ivo A. Olivotto, Soon Young Paik, Hongchao Pan, Richárd Pető, Martine Piccart, Lori J. Pierce, Philip Poortmans, Trevor J. Powles, K.I. Pritchard, Joseph Ragaz, Vinod Raina, Peter M. Ravdin, Simon Read, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Suzy Scholl, Dennis J. Slamon, Lidija Sölkner, Joseph A. Sparano, Seth M. Steinberg, Rosemary Sutcliffe, Sandra M. Swain, Carolyn Taylor, Andrew Tutt, Pinuccia Valagussa, Cornelis J.�H. van de Velde, Jos A. van der Hage, Giuseppe Viale, Gϋnter von Minckwitz ほか 10 名 - The Lancet Oncology 2017 被引用: 1,133

  4. Ki67 in breast cancer: prognostic and predictive potential

    著者: Rinat Yerushalmi, Ryan Woods, Peter M. Ravdin, Malcolm Hayes, Karen A. Gelmon - The Lancet Oncology 2010 被引用: 1,226

  5. Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

    著者: Joseph A. Sparano, Robert J. Gray, Peter M. Ravdin, Della Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, John A. Olson, Tracy Lively, Sunil Badve, Thomas J. Saphner, Lynne I. Wagner, Timothy J. Whelan, Matthew J. Ellis, Soonmyung Paik, William C. Wood, Maccon Keane, Henry Gómez, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Adam Brufsky, Deborah Toppmeyer, Virginia Kaklamani, Jeffrey L. Berenberg, Jeffrey S. Abrams, George W. Sledge - New England Journal of Medicine 2019 被引用: 555

  6. Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

    著者: Joseph A. Sparano, Robert J. Gray, Della Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Edith A. Perez, John A. Olson, JoAnne Zujewski, Tracy Lively, Sunil Badve, Thomas J. Saphner, Lynne I. Wagner, Timothy J. Whelan, Matthew J. Ellis, Soonmyung Paik, William C. Wood, Peter M. Ravdin, Maccon Keane, Henry Gómez, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Adam Brufsky, Deborah Toppmeyer, Virginia Kaklamani, James N. Atkins, Jeffrey L. Berenberg, George W. Sledge - New England Journal of Medicine 2015 被引用: 1,439

  7. 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

    著者: Martine Piccart, Laura van ‘t Veer, Coralie Poncet, Josephine Lopes Cardozo, Suzette Delaloge, Jean‐Yves Pierga, Peter Vuylsteke, Étienne Brain, Suzan Vrijaldenhoven, Peter A. Neijenhuis, S. Causeret, Tineke J. Smilde, Giuseppe Viale, Annuska M. Glas, Mauro Delorenzi, Christos Sotiriou, Isabel T. Rubio, Sherko Kümmel, Gabriele Zoppoli, Alastair M. Thompson, Erika Matos, Khalil Zaman, Florentine Hilbers, Debora Fumagalli, Peter M. Ravdin, Susan Knox, Konstantinos Tryfonidis, Aleksandra Peric, Bart Meulemans, Jan Bogaerts, Fátima Cardoso, Emiel J. Rutgers - The Lancet Oncology 2021 被引用: 358

  8. The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine

    著者: Jeffrey S. Ross, Elzbieta Slodkowska, W. Fraser Symmans, Lajos Pusztai, Peter M. Ravdin, Gabriel N. Hortobágyi - The Oncologist 2009 被引用: 1,153

  9. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

    著者: Kathy S. Albain, William E. Barlow, Steven Shak, Gabriel N. Hortobágyi, Robert B. Livingston, I‐Tien Yeh, Peter M. Ravdin, Roberto Bugarini, Frederick L. Baehner, Nancy E. Davidson, George W. Sledge, Eric P. Winer, Clifford A. Hudis, James N. Ingle, Edith A. Perez, Kathleen I. Pritchard, Lois E. Shepherd, Julie R. Gralow, Carl Yoshizawa, D. Craig Allred, C. Kent Osborne, Daniel F. Hayes - The Lancet Oncology 2009 被引用: 1,405

  10. American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

    著者: Lyndsay N. Harris, Herbert A. Fritsche, Robert Mennel, Larry Norton, Peter M. Ravdin, Sheila E. Taube, Mark R. Somerfield, Daniel F. Hayes, Robert C. Bast - Journal of Clinical Oncology 2007 被引用: 2,216

  11. Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women

    著者: Rowan T. Chlebowski, Garnet L. Anderson, Margery Gass, Dorothy S. Lane, Aaron K. Aragaki, Lewis H. Kuller, JoAnn E. Manson, Marcia L. Stefanick, Judith K. Ockene, Gloria E. Sarto, Karen Johnson, Jean Wactawski‐Wende, Peter M. Ravdin, Robert S. Schenken, Susan L. Hendrix, Aleksandar Rajkovic, Thomas E. Rohan, Shagufta Yasmeen, Ross L. Prentice, for the WHI Investigators - JAMA 2010 被引用: 565

  12. High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller

    著者: Ana M. González-Angulo, Jennifer K. Litton, Kristine Broglio, Funda Meric‐Bernstam, Ronjay Rakkhit, Fátima Cardoso, Florentia Peintinger, Emer O. Hanrahan, Ayşegül A. Şahin, Merih Güray, Denis Larsimont, Francesco Feoli, Heidi Stranzl, Thomas A. Buchholz, Vicente Valero, Richard L. Theriault, Martine Piccart, Peter M. Ravdin, Donald A. Berry, Gabriel N. Hortobágyi - Journal of Clinical Oncology 2009 被引用: 467

  13. The Decrease in Breast-Cancer Incidence in 2003 in the United States

    著者: Peter M. Ravdin, Kathleen A. Cronin, Nadia Howlader, Christine D. Berg, Rowan T. Chlebowski, Eric J. Feuer, Brenda K. Edwards, Donald A. Berry - New England Journal of Medicine 2007 被引用: 977

  14. Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer

    著者: Stephen E. Jones, John K. Erban, Beth Overmoyer, G. T. Budd, Laura F. Hutchins, EE Lower, Leslie Rodgers Laufman, S. Sundaram, W J Urba, Kathleen I. Pritchard, Robert Mennel, Donald Richards, Steven R. Olsen, Marlene Meyers, Peter M. Ravdin - Journal of Clinical Oncology 2005 被引用: 547

  15. Computer Program to Assist in Making Decisions About Adjuvant Therapy for Women With Early Breast Cancer

    著者: Peter M. Ravdin, Laura A. Siminoff, Greg Davis, Mary Beth Mercer, Joan Hewlett, Nancy Gerson, Helen L. Parker - Journal of Clinical Oncology 2001 被引用: 1,009

  16. Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers

    著者: D. F. Hayes, Robert C. Bast, Christopher E. Desch, Herbert A. Fritsche, Nancy E. Kemeny, J. Milburn Jessup, Gershon Y. Locker, J. S. Macdonald, Robert Mennel, Larry Norton, Peter M. Ravdin, Sheila E. Taube, R Winn - JNCI Journal of the National Cancer Institute 1996 被引用: 752

  17. NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry

    著者: D. Craig Allred, Robert W. Carlson, Donald A. Berry, Harold J. Burstein, Stephen B. Edge, Lori J. Goldstein, Allen M. Gown, M. Elizabeth Hammond, J. Dirk Iglehart, Susan J. Moench, Lori J. Pierce, Peter M. Ravdin, Stuart J. Schnitt, Antonio C. Wolff - Journal of the National Comprehensive Cancer Network 2009 被引用: 142

  18. Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women

    著者: Rowan T. Chlebowski, Lewis H. Kuller, Ross L. Prentice, Marcia L. Stefanick, JoAnn E. Manson, Margery Gass, Aaron K. Aragaki, Judith K. Ockene, Dorothy S. Lane, Gloria E. Sarto, Aleksandar Rajkovic, Robert S. Schenken, Susan L. Hendrix, Peter M. Ravdin, Thomas E. Rohan, Shagufta Yasmeen, Garnet L. Anderson - New England Journal of Medicine 2009 被引用: 468

  19. Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer

    著者: Wendy A. Woodward, William E. Barlow, Reshma Jagsi, Thomas A. Buchholz, Steven Shak, Frederick L. Baehner, Timothy J. Whelan, Nancy E. Davidson, James N. Ingle, Tari A. King, Peter M. Ravdin, C. Kent Osborne, Debasish Tripathy, Robert B. Livingston, Julie R. Gralow, Gabriel N. Hortobágyi, Daniel F. Hayes, Kathy S. Albain - JAMA Oncology 2020 被引用: 77

  20. 2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*

    著者: Robert C. Bast, Peter M. Ravdin, Daniel F. Hayes, Susan Bates, Herbert A. Fritsche, J. Milburn Jessup, Nancy E. Kemeny, Gershon Y. Locker, Robert Mennel, Mark R. Somerfield - Journal of Clinical Oncology 2001 被引用: 886

  21. Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer

    著者: Ivo A. Olivotto, Chris Bajdik, Peter M. Ravdin, Caroline Speers, Andrew J. Coldman, B. Norris, Greg Davis, Stephen Chia, Karen A. Gelmon - Journal of Clinical Oncology 2005 被引用: 572

  22. Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

    著者: René Bruno, Darcy A. Hille, A. Riva, Nicole Vivier, W.W. ten Bokkel Huinnink, A.T. van Oosterom, S.B. Kaye, Jaap Verweij, Frank V. Fossella, Vicente Valero, James R. Rigas, Andrew D. Seidman, B Chevallier, P. Fumoleau, Howard A. Burris, Peter M. Ravdin, Lewis B. Sheiner - Journal of Clinical Oncology 1998 被引用: 423

  23. Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

    著者: Kathy S. Albain, William E. Barlow, Peter M. Ravdin, William B. Farrar, Gary V. Burton, Steven J. Ketchel, Charles D. Cobau, Ellis Levine, James N. Ingle, Kathleen I. Pritchard, Allen S. Lichter, Daniel J. Schneider, Martin D. Abeloff, I. Craig Henderson, Hyman B. Muss, Stephanie Green, Danika L. Lew, Robert B. Livingston, Silvana Martino, C. Kent Osborne - The Lancet 2009 被引用: 259

  24. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study

    著者: Stella Mook, Marjanka K. Schmidt, Emiel J. Rutgers, Anthonie O. van de Velde, Otto Visser, Sterre M Rutgers, Nicola J. Armstrong, Laura J. van’t Veer, Peter M. Ravdin - The Lancet Oncology 2009 被引用: 177